دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
What does the licensing of teplizumab mean for diabetes care?
Lauren M. Quinn MBChB, Rabbi Swaby BMBS, Danijela Tatovic PhD, Parth Narendran PhD, Rachel E. J. Besser PhD, Colin M. Dayan PhD,Â
doi : 10.1111/dom.15071
New insights into the treatment of obesity
Matthias Blüher MD, Mohini Aras MD, Louis J. Aronne MD, Rachel L. Batterham MD, Francesco Giorgino MD, Linong Ji MD, Kirsi H. Pietiläinen MD, Oliver Schnell MD, Elena Tonchevska MSc, John P.H. Wilding MD,Â
doi : 10.1111/dom.15077
Association of glycation gap with all-cause and cardiovascular mortality in US adults: A nationwide cohort study
Lingfeng Gu MD, Sibo Wang MD, Chong Du MD, Bo Deng MD, Yao Ma MD, Tongtong Yang PhD, Tiankai Shan PhD, Jiateng Sun MD, Hao Wang MD, Liansheng Wang MD,Â
doi : 10.1111/dom.15078
Efficacy and safety of once-weekly efpeglenatide in people with suboptimally controlled type 2 diabetes: The AMPLITUDE-D, AMPLITUDE-L and AMPLITUDE-S randomized controlled trials
Vanita R. Aroda MD, Juan Pablo Frias MD, Linong Ji MD, Elisabeth Niemoeller MD, My-Liên Nguyên-Pascal MD, Karl Denkel B.Eng, Melanie Espinasse MS, Hailing Guo MSc, SeungJae Baek MD, JaeDuk Choi PhD, Ildiko Lingvay MD,Â
doi : 10.1111/dom.15079
Efficacy and safety of monotherapy with enavogliflozin in Korean patients with type 2 diabetes mellitus: Results of a 12-week, multicentre, randomized, double-blind, placebo-controlled, phase 2 trial
Ye Seul Yang MD, Kyung Wan Min MD, Seok-O Park MD, Kyung-Soo Kim MD, Jae Myung Yu MD, Eun-Gyoung Hong MD, Sung Rae Cho MD, Kyu Chang Won MD, Yong Hyun Kim MD, Seungjoon Oh MD, Sung Hee Choi MD, Gwanpyo Koh MD, Wan Huh MS, Su Young Kim MS, Kyong Soo Park MD,Â
doi : 10.1111/dom.15080
Control of human pancreatic beta cell kinome by glucagon-like peptide-1 receptor biased agonism
Jiannan Xiao MSc, Liliane El Eid MRes, Teresa Buenaventura PhD, Raphaël Boutry PhD, Amélie Bonnefond PhD, Ben Jones MD, Guy A. Rutter PhD, Philippe Froguel MD, Alejandra Tomas PhD,Â
doi : 10.1111/dom.15083
Longitudinal study investigating serum metabolites and their association with type 2 diabetes risk in a Korean population
Youngae Jung PhD, Eunyong Ahn PhD, Taesung Park PhD, Geum-Sook Hwang PhD,Â
doi : 10.1111/dom.15084
Comparison of the effects of sitagliptin and dapagliflozin on time in range in Japanese patients with type 2 diabetes stratified by body mass index: A sub-analysis of the DIVERSITY-CVR study
Kota Takuma MD, Ayako Fuchigami MD, Fumika Shigiyama MD, Naoki Kumashiro MD, Takahisa Hirose MD,Â
doi : 10.1111/dom.15089
The improved health utility of once-weekly subcutaneous semaglutide 2.4 mg compared with placebo in the STEP 1-4 obesity trials
Jakob Bue Bjorner MD, Sara Larsen MSc, Christopher Lübker PhD, Thomas Holst-Hansen PhD,Â
doi : 10.1111/dom.15090
The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trials
Amy Kang MBBS (Hons), Brendan Smyth PhD, Brendon L. Neuen MBBS (Hons), Hiddo J. L. Heerspink PhD, Gian Luca Di Tanna PhD, Hong Zhang MD, Clare Arnott PhD, Carinna Hockham PhD, Rajiv Agarwal MD, George Bakris MD, David M. Charytan MD, Dick de Zeeuw PhD, Tom Greene PhD, Adeera Levin MD, Carol Pollock PhD, David C. Wheeler MD, Kenneth W. Mahaffey MD, Vlado Perkovic PhD, Meg J. Jardine PhD,Â
doi : 10.1111/dom.15091
Effect of multifactorial intensive treatment in patients with diabetic kidney disease: A meta-analysis with trial sequential analysis
Jianfang Shan BD, Zhengling Xu BD,Â
doi : 10.1111/dom.15093
Brain insulin responsiveness is linked to age and peripheral insulin sensitivity
Lore Wagner MSc, Ralf Veit PhD, Christian Kübler MD, Andreas Fritsche MD, Hans-Ulrich Häring MD, Andreas L. Birkenfeld MD, Martin Heni MD, Hubert Preissl PhD, Stephanie Kullmann PhD,Â
doi : 10.1111/dom.15094
Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: The gemi-heart study
Seung Min Chung MD, Jun Sung Moon MD, Jun Hwa Hong MD, In-Chang Hwang MD, Soo Lim MD,Â
doi : 10.1111/dom.15095
Continuous glucose monitoring in patients with post-bariatric hypoglycaemia reduces hypoglycaemia and glycaemic variability
Cameron Cummings BS, Alex Jiang BS, Amanda Sheehan FNP, Rafael Ferraz-Bannitz PhD, Alexa Puleio BS, Donald C. Simonson MD, Jonathan M. Dreyfuss PhD, Mary Elizabeth Patti MD,Â
doi : 10.1111/dom.15096
Glycated albumin and risk of cardiovascular diseases and mortality in patients with and without dialysis: A meta-analysis
Huilei Zhao MD, Qingwen Hu MD, Jiawei Chen MD, Qin Ling MD, Zhiwei Yan MD, Peng Yu MD, Jing Zhang MD, Xiao Liu MD,Â
doi : 10.1111/dom.15097
Safety, tolerability, pharmacodynamics and pharmacokinetics of the soluble guanylyl cyclase activator BI 685509 in patients with diabetic kidney disease: A randomized trial
David Z. I. Cherney MD, Dick de Zeeuw PhD, Hiddo J. L. Heerspink PhD, Jose Cardona MD, Marc Desch MD, Arne Wenz, Friedrich Schulze PhD, Masaomi Nangaku MD,Â
doi : 10.1111/dom.15099
Incidence and predictors of remission and relapse of type 2 diabetes mellitus in Japan: Analysis of a nationwide patient registry (JDDM73)
Kazuya Fujihara MD, Laymon Khin MD, Koshiro Murai MD, Yurie Yamazaki MD, Kahori Tsuruoka RN, Noriko Yagyuda RN, Katsuya Yamazaki MD, Hiroshi Maegawa MD, Shiro Tanaka PhD, Satoru Kodama MD, Hirohito Sone MD, JDDM Study Group ,Â
doi : 10.1111/dom.15100
Orlistat mouth rinse: Using the tongue to deliver antiobesity medication in a double-blind randomized crossover pilot trial
Stefany D. Primeaux PhD, Robert Dubin MD, Frank L. Greenway MD,Â
doi : 10.1111/dom.15101
Impact of severe hypoglycaemia requiring hospitalization on mortality in people with type 1 diabetes: A national retrospective observational cohort study
Othmar Moser PhD, James Rafferty, Max L. Eckstein, Faisal Aziz, Stephen C. Bain, Richard Bergenstal, Harald Sourij, Rebecca L. Thomas,Â
doi : 10.1111/dom.15102
Bile acid metabolites in early pregnancy and risk of gestational diabetes mellitus: Results from a prospective cohort study
Yuwan Wu MSc, Zheng Wang PhD, Zhi Zhao PhD, Xiuxia Song PhD, Maohua Miao PhD, Xi Zhang PhD,Â
doi : 10.1111/dom.15104
Use of hospital care among Dutch diabetes patients
Silvia A. G. de Vries MD, Jessica C. G. Bak MD, Vincent A. Stangenberger MSc, Michel W. J. M. Wouters MD, Max Nieuwdorp MD, Theo C. J. Sas MD, Carianne L. Verheugt MD,Â
doi : 10.1111/dom.15105
Long-acting insulin analogues and the risk of diabetic retinopathy among patients with type 2 diabetes: A population-based cohort study
Stéphanie Larose MD, Christopher Filliter MSc, Robert W. Platt PhD, Oriana H. Y. Yu MD, Kristian B. Filion PhD,Â
doi : 10.1111/dom.15106
Safety/tolerability, efficacy and pharmacokinetics of 600-μg cotadutide in Japanese type 2 diabetes patients with a body mass index of 25 kg/m2 or higher: A phase I, randomized, double-blind, placebo-controlled study
Michiko Asano MD, Akiko Sekikawa MSc, Masatoshi Sugeno PhD, Osamu Matsuoka MD, Darren Robertson PhD, Lars Hansen MD,Â
doi : 10.1111/dom.15107
Glycaemia and cardiac arrhythmias in people with type 1 diabetes: A prospective observational study
Per G. Hagelqvist MD, Andreas Andersen PhD, Kaisar Maytham BSc, Christine R. Andreasen PhD, Susanne Engberg PhD, Tommi B. Lindhardt PhD, Julie L. Forman PhD, Ulrik Pedersen-Bjergaard DMSc, Filip K. Knop PhD, Tina Vilsbøll DMSc,Â
doi : 10.1111/dom.15108
Sodium-glucose cotransporter-2 inhibitors and kidney outcomes in real-world type 2 diabetes populations: A systematic review and meta-analysis of observational studies
Anna K. Forbes MBChB, Rebecca J. Suckling PhD, William Hinton MSc, Michael D. Feher FRCP, Debasish Banerjee FRCP, Nicholas I. Cole MD (Res), Simon de Lusignan MD, Pauline A. Swift PhD,Â
doi : 10.1111/dom.15111
Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials
Vikas S. Sridhar MD, Brendon L. Neuen PhD, Robert A. Fletcher MSc, April Slee PhD, Fernando G. Ang MD, Wally Rapattoni BPharm, Clare Arnott PhD, David Z. Cherney MD, Vlado Perkovic PhD, David C. Wheeler MD, Adeera Levin MD,Â
doi : 10.1111/dom.15112
Effect of the glucagon-like peptide-1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: A randomized trial in adults with obesity and prediabetes
Heidi J. Silver PhD, Dianna Olson RD, Dustin Mayfield RN, Patricia Wright RN, Hui Nian PhD, Mona Mashayekhi MD, John R. Koethe MD, Kevin D. Niswender MD, James M. Luther MD, Nancy J. Brown MD,Â
doi : 10.1111/dom.15113
The lifetime health and economic burden of obesity in five European countries: what is the potential impact of prevention?
Martine Hoogendoorn PhD, Milanne Galekop MSc, Pieter van Baal PhD,Â
doi : 10.1111/dom.15116
Metabolic bariatric surgery as a therapeutic option for patients with type 2 diabetes: A meta-analysis and network meta-analysis of randomized controlled trials
Maurizio De Luca MD, Monica Zese MD, Giulia Bandini MD, Sonja Chiappetta MD, Angelo Iossa MD, Giovanni Merola MD, Giacomo Piatto MD, Salvatore Tolone MD, Antonio Vitiello MD, Giovanni Antonio Silverii MD, Benedetta Ragghianti MD, Edoardo Mannucci MD, Matteo Monami MD, Expert Panel and Evidence Review Team for the Italian Guidelines on Bariatric and Metabolic Surgery ,Â
doi : 10.1111/dom.15117
Altered high-density lipoprotein composition is associated with risk for complications in type 2 diabetes mellitus in South Asian descendants: A cross-sectional, case-control study on lipoprotein subclass profiling
Lushun Yuan MD, Ruifang Li-Gao MSc, Aswin Verhoeven PhD, Huub J. van Eyk MD, Maurice B. Bizino MD, Patrick C. N. Rensen PhD, Martin Giera PhD, Ingrid M. Jazet MD, Hildo J. Lamb MD, Ton J. Rabelink MD, Bernard M. van den Berg PhD,Â
doi : 10.1111/dom.15118
Semaglutide reduces the risk of major adverse cardiovascular events consistently across baseline triglyceride levels in patients with type 2 diabetes: Post hoc analyses of the SUSTAIN 6 and PIONEER 6 trials
Subodh Verma MD, Jens-Peter David PhD, Lawrence A. Leiter MD, Marie Mide Michelsen PhD, Søren Rasmussen PhD, Deepak L. Bhatt MD,Â
doi : 10.1111/dom.15081
The effects of kisspeptin on food intake in women with overweight or obesity
Chioma Izzi-Engbeaya MBBS, Muhammad M. Choudhury MRes, Bijal Patel MBBS, Beatrice Muzi BSc, Ambreen Qayuum MBBS, Edouard G. Mills MBBS, Maheen Ahsan MBBS, Maria Phylactou MBBS, Sophie A. Clarke MBBS, Laura Aslett BSc, Alexander N. Comninos MBBS, Ali Abbara MBBS, Tricia M. Tan MBChB, Waljit S. Dhillo MBBS,Â
doi : 10.1111/dom.15086
Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: Post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials
Subodh Verma MD, Mansoor Husain MD, Christian M. Madsen MD, Lawrence A. Leiter MD, Anja Birk Kuhlman MD, Tina Vilsbøll MD, Søren Rasmussen PhD, Peter Libby MD,Â
doi : 10.1111/dom.15088
Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study
Su-Yen Goh MD, Mikhail N. Kosiborod MD, Carolyn S. P. Lam MD, Matthew A. Cavender MD, Shun Kohsaka MD, Anna Norhammar MD, KÃ¥re I. Birkeland MD, Reinhard W. Holl MD, DÃdac Mauricio MD, Navdeep Tangri MD, Jonathan E. Shaw MD, Marcus Thuresson PhD, Peter Fenici MD, Dae Jung Kim MD, on behalf of the CVD-REAL Investigators and Study Group ,Â
doi : 10.1111/dom.15092
Effects of atrasentan on markers of liver function in patients with type 2 diabetes and chronic kidney disease
Donald E. Kohan MD, Adrian Liew MD, Sydney C. W. Tang MD, Jonathan Barratt MD, Hiddo J. L. Heerspink PhD,Â
doi : 10.1111/dom.15103
Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials
Taha Sen PharmD, Viktor Rotbain Curovic MD, Niels Jongs PhD, Gozewijn D. Laverman PhD, Adriaan Kooy PhD, Frederik Persson PhD, Peter Rossing PhD, Hiddo J. L. Heerspink PhD,Â
doi : 10.1111/dom.15109
Diuretic medication and change in fluid retention biomarkers during treatment with the endothelin receptor antagonist atrasentan
J. David Smeijer MD, Donald E. Kohan MD, Dick de Zeeuw MD, Hiddo J. L. Heerspink PhD,Â
doi : 10.1111/dom.15110
Inclusion of drugs on the World Health Organization's Essential Medicines List: A game-changer for obesity?
Rajmohan Seetharaman MD,Â
doi : 10.1111/dom.15114
